Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Psychiatrische Praxis|December 1, 2004
[Treatment of patients with personality disorders in specialized units for psychotherapy in Bavarian psychiatric hospitals]Thomas Schmelter, Rosemarie Bauer
Pharmaceutical Statistics|September 21, 2011
Determining the non-inferiority margin for patient reported outcomesChristoph Gerlinger, Thomas Schmelter
Obstetrics and Gynecology|May 3, 2013
Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trialTerje Sørdal, Pirjo Inki, John Draeby, et al.
Menopause (New York, N.Y.)|January 10, 2012
An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal womenChristoph Gerlinger, Kerstin Gude, Florian Hiemeyer, et al.
Menopause (New York, N.Y.)|August 22, 2013
A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal womenDavid F Archer, Thomas Schmelter, Matthias Schaefers, et al.
Seminars in Fetal & Neonatal Medicine|April 26, 2022
Using real-world data in pediatric clinical trials: Lessons learned and future applications in studies of persistent pulmonary hypertension of the newbornThomas F Miller, Andreas Kaiser, Thomas Schmelter, et al.
Contraception|February 10, 2015
Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine systemGerard G Nahum, Andrew M Kaunitz, Kimberly Rosen, et al.
Menopause (New York, N.Y.)|August 22, 2013
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptomsGabriele Sutter, Thomas Schmelter, Kerstin Gude, et al.
Biotechnology Journal|March 22, 2022
Rapid production of SaCas9 in plant-based cell-free lysate for activity testingAndreas Schiermeyer, Pedro Cerda-Bennasser, Thomas Schmelter, et al.
Plos One|September 18, 2015
The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III TrialKristina Gemzell-Danielsson, Dan Apter, Brian Hauck, et al.
Pageof 5